Search - tctmd.com

Displaying 1 - 20 of 28

Sort: Relevancy | Date

News Daily News

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Todd Neale

December 26, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Conference News ESC 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

Caitlin E. Cox

September 10, 2024

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

L.A. McKeown

August 19, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Conference News ISET 2019

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

Caitlin E. Cox

January 28, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Conference News VIVA 2018

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

L.A. McKeown

November 15, 2018

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

Presentation TCT 2014

Against the Proposal!

Presenter: John R. Laird Jr

September 14, 2014

Presentation TCT 2014

For the Proposal!

Presenter: Mehdi H. Shishehbor

September 14, 2014

Presentation TCT 2014

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Presenter: Lawrence A. Garcia, Richard M. Green, Douglas E. Drachman, Takao Ohki, MD

September 14, 2014

Presentation TCT 2014

Appropriate Use Criteria in the Periphery: Status Update

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Sahil A. Parikh

September 14, 2014

Presentation TCT 2014

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Mark H. Wholey

September 14, 2014

Presentation TCT 2014

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Raghu Kolluri

September 14, 2014

Presentation TCT 2014

The BEST and BASIL 2 Studies: Designs and Goals

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Kenneth Rosenfield

September 14, 2014

Presentation TCT 2014

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Karl-Ludwig Schulte

September 14, 2014

Advertisement

Year in Review: STORM-PE, CREST-2, and LIFE-BTK Headline Endovascular News

Top Endovascular News of 2024

New ESC Guidelines Merge PAD, Aortic Diseases Into Single Document

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

March 2024 Dispatch for the CV Team

Top Endovascular News of 2023

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

PAD in the Spotlight: Awareness, Treatment Remain Low Despite Many Years of Research

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Consulting the COMPASS for Rivaroxaban’s Role in Peripheral Vascular Disease

Next-Generation Large-Bore Closure Devices Arrive

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Against the Proposal!

For the Proposal!

TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY)

Appropriate Use Criteria in the Periphery: Status Update

Managing Acute Limb Ischemia: Which Patients Get Endovascular and When Is Bypass Preferred?

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

The BEST and BASIL 2 Studies: Designs and Goals

Randomized Trial Outcomes: POBA vs Stenting in Infrapopliteal Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content